Association of A1C and Fasting Plasma Glucose Levels With Diabetic Retinopathy Prevalence in the U.S. Population
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association of A1C levels and fasting plasma glucose (FPG) with diabetic retinopathy in the U.S. population and to compare the ability of the two glycemic measures to discriminate between people with and without retinopathy. RESEARCH DESIGN AND METHODS: This study included 1,066 individuals aged ≥40 years from the 2005–2006 National Health and Nutrition Examination Survey. A1C, FPG, and 45° color digital retinal images were assessed. Retinopathy was defined as a level ≥14 on the Early Treatment Diabetic Retinopathy Study severity scale. We used joinpoint regression to identify linear inflections of prevalence of retinopathy in the association between A1C and FPG. RESULTS: The overall prevalence of retinopathy was 11%, which is appreciably lower than the prevalence in people with diagnosed diabetes (36%). There was a sharp increase in retinopathy prevalence in those with A1C ≥5.5% or FPG ≥5.8 mmol/l. After excluding 144 people using hypoglycemic medication, the change points for the greatest increase in retinopathy prevalence were A1C 5.5% and FPG 7.0 mmol/l. The coefficients of variation were 15.6 for A1C and 28.8 for FPG. Based on the areas under the receiver operating characteristic curves, A1C was a stronger discriminator of retinopathy (0.71 [95% CI 0.66–0.76]) than FPG (0.65 [0.60 – 0.70], P for difference = 0.009). CONCLUSIONS: The steepest increase in retinopathy prevalence occurs among individuals with A1C ≥5.5% and FPG ≥5.8 mmol/l. A1C discriminates prevalence of retinopathy better than FPG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Diabetic Retinopathy in a Multi-ethnic Cohort in the United States
Wong, T. Y., Klein, R., Islam, F. M. A., Cotch, M. F., Folsom, A. R., Klein, B. E. K., Sharrett, A. R., & Shea, S. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.063 · Cited by 684 · cited 1×
“Moreover, retinopathy in the absence of diabetes (FPG 7 mmol/l) was more frequent among individuals of minority racial groups than whites (16), suggesting a higher likelihood of retinopathy not due to hyperglycemia among minority populations.”
BackgroundSelf-citationHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
McCane, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. D., Bennett, P. H., & Knowler, W. C. (1994) · BMJ · doi:10.1136/bmj.308.6940.1323 · Cited by 484 · cited 3×
“Second, we applied the cut points used in an analysis of the Pima Indians (2).”
BackgroundMethodResultInfluential
Cited by
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Self-citationPioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Perreault, L., Pan, Q., Mather, K. J., Watson, K. E., Hamman, R. F., & Kahn, S. E. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60525-x · Cited by 532
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 492
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000230 · Cited by 386
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
Selvin, E., Rawlings, A. M., Grams, M., Klein, R., Sharrett, A. R., Steffes, M., & Coresh, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70199-2 · Cited by 262
Self-citationPrevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study
Mainous, A. G., Tanner, R. J., Baker, R., Zayas, C. E., & Harle, C. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005002 · Cited by 187
Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients
Sánchez-Pernaute, A., Rubio, M. Á., Cabrerizo, L., Ramos-Levi, A., Pérez-Aguirre, E., & Torres, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.01.024 · Cited by 174
“7%, which is the level for patients in risk for developing diabetes and microangiopathy [19].”
BackgroundTen Emerging Trends in the Epidemiology of Diabetic Retinopathy
Sabanayagam, C., Yip, W., Ting, D. S. W., Tan, G., & Wong, T. Y. (2016) · Ophthalmic Epidemiology · doi:10.1080/09286586.2016.1193618 · Cited by 159
Prediabetes and associated disorders
Buysschaert, M., Medina, J. L., Bergman, M., Shah, A., & Lonier, J. (2014) · Endocrine · doi:10.1007/s12020-014-0436-2 · Cited by 183
Buysschaert, M., & Bergman, M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.002 · Cited by 176
Perreault, L., Temprosa, M., Mather, K. J., Horton, E., Kitabchi, A., Larkin, M., Montez, M. G., Thayer, D., Orchard, T. J., Hamman, R. F., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0656 · Cited by 131
“HDL (mg/dL) 44 (11) 46 (12) 46 (12) ,0.”
Blackstone, R. P., Bunt, J. C., Cortés, M. C., & Sugerman, H. J. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.05.005 · Cited by 135
Implications of Using Hemoglobin A1C for Diagnosing Diabetes Mellitus
Malkani, S., & Mordes, J. P. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.025 · Cited by 146
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland
on behalf of the Scottish Diabetic Retinopathy Screening Collaborative and the Scottish Diabetes Research Network Epidemiology Group, Looker, H. C., Nyangoma, S. O., Cromie, D., Olson, J. A., Leese, G. P., Black, M., Doig, J., Lee, N., Lindsay, R. S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2596-z · Cited by 110
Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc16-0042 · Cited by 96
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Liu, X., Wu, S., Song, Q., & Wang, X. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019045 · Cited by 78
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme
Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Black, M. W., Doig, J., Lee, N., Lindsay, R. S., McKnight, J. A., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303948 · Cited by 76
Physiology and its importance for reference intervals.
Sikaris, K. A. (2014) · Europe PMC (PubMed Central) · Cited by 102
Perreault, L., & Færch, K. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.008 · Cited by 92
“5% (Cheng et al. 2009), which would be considered normoglycemia by current ADA and WHO criteria.”
BackgroundPlasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy
Jiang, Q., Lyu, X., Yuan, Y., & Wang, L. (2017) · Bioscience Reports · doi:10.1042/bsr20160589 · Cited by 78
Sanz, C. M., Ruidavets, J.-B., Bongard, V., Marquié, J.-C., Hanaire, H., Ferrières, J., & Andrieu, S. (2013) · Diabetes Care · doi:10.2337/dc12-1017 · Cited by 60
“An increase in glycemia is linked to an increase in retinopathy prevalence (30).”
BackgroundPlasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy
Zou, H., Wang, Y., Gang, Q., Zhang, Y., & Sun, Y. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3638-5 · Cited by 67
“Also, identification of these changes is valuable for determining the lowest cut-point for DR diagnosis [22].”
BackgroundThe Relationship Between β-Cell Function and Glycated Hemoglobin
Kanat, M., Winnier, D., Norton, L., Arar, N., Jenkinson, C., DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · Diabetes Care · doi:10.2337/dc10-1352 · Cited by 58
“For example, the threshold for the increase in retinopathy was 5.5% in the 2005–2006 National Health and Nutrition Examination Survey (15) and the Hisayama study (16), 6.0% in the National Health and Nutrition Examination Survey III (17), 6.2% in the Pima Indian study (18), and 6.3% in the Egyptian study (19).”
BackgroundInfluentialPrevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis
Merlotti, C., Morabito, A., Ceriani, V., & Pontiroli, A. E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0624-9 · Cited by 64
Emerging trends in optical sensing of glycemic markers for diabetes monitoring
Pandey, R., Dingari, N. C., Spegazzini, N., Dasari, R. R., Horowitz, G. L., & Barman, I. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2014.09.005 · Cited by 53
“Unlike measurement of fasting plasma glucose (FPG), HbA1c and fructosamine do not require an overnight fast, are not affected by short-term lifestyle changes, and show significantly less variability within individuals [4].”
BackgroundSalivary proteins associated with hyperglycemia in diabetes: a proteomic analysis
Bencharit, S., Baxter, S. S., Carlson, J., Byrd, W. C., Mayo, M. V., Border, M. B., Kohltfarber, H., Urrutia, E., Howard-Williams, E. L., Offenbacher, S., et al. (2013) · Molecular BioSystems · doi:10.1039/c3mb70196d · Cited by 57
Silverman, R. A., Thakker, U., Ellman, T., Wong, I., Smith, K. N., Ito, K., & Graff, K. (2011) · Diabetes Care · doi:10.2337/dc10-0996 · Cited by 59
“In addition, our findings are consistent with reports from more recent studies that use retinopathy as the criterion for identifying glycemicrelated vascular disease (14,15).”
ResultHemoglobin A 1c and diagnosis of diabetes
Ding, L., Xu, Y., Liu, S., Bi, Y., & Xu, Y. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12640 · Cited by 70
“5%.(61) A study from Japan reported that the optimal HbA1c value associated with future retinopathy was 5.”
BackgroundPrevention and Treatment of Diabetic Retinopathy: Evidence from Clinical Trials and Perspectives
Abbate, M., Cravedi, P., Iliev, I. P., Remuzzi, G., & Ruggenenti, P. L. (2011) · Current Diabetes Reviews · doi:10.2174/157339911795843168 · Cited by 58
No Ethnic Differences in the Association of Glycated Hemoglobin With Retinopathy
Bower, J. K., Brancati, F. L., & Selvin, E. (2013) · Diabetes Care · doi:10.2337/dc12-0404 · Cited by 48
Kowall, B., & Rathmann, W. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s39093 · Cited by 60
Ceyhan, K., Kadı, H., Koç, F., Çelik, A., Öztürk, A., & Önalan, O. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.11.018 · Cited by 49
“%) by resting echocardiography; poor-quality echocardiographic imaging; valvular or congenital heart disease; previous surgical or percutaneous revascularization; or endocrine and systemic diseases other than DM.”
ResultInfluentialVenkataraman, K., Kao, S. L., Thai, A. C., Salim, A., Lee, J. J. M., Heng, D., Tai, E. S., & Khoo, E. Y. H. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03599.x · Cited by 45
Graue-Hernández, E. O., la Parra, D. R.-D., Hernández-Jiménez, S. C., Aguilar-Salinas, C. A., Kershenobich, D., & Jiménez-Corona, A. (2020) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2019-000304 · Cited by 47
Treating prediabetes: why and how should we do it?
Braga, T. G., Kraemer‐Aguiar, L. G., Docherty, N. G., & le Roux, C. W. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05897-4 · Cited by 45
Zhang, X., Zhao, J., Zhao, T., & Liu, H. (2014) · Endocrine · doi:10.1007/s12020-014-0459-8 · Cited by 44
Self-citationYu, G., Aaberg, M. T., Patel, T. P., Iyengar, R., Powell, C. C., Tran, A. P., Miranda, C., Young, E., Demetriou, K., Devisetty, L. V., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.1257 · Cited by 42
Yin, C., Lin, X., Sun, Y., & Ji, X. (2020) · European journal of medical research · doi:10.1186/s40001-020-00416-3 · Cited by 41
Tabák, Á. G., Brunner, E. J., Lindbohm, J. V., Singh‐Manoux, A., Shipley, M. J., Sattar, N. A., & Kivimäki, M. (2022) · Circulation · doi:10.1161/circulationaha.122.059430 · Cited by 39
Pujol, J., Christinat, N., Ratinaud, Y., Savoia, C., Mitchell, E. S., & Dioum, E. M. (2018) · Nutrients · doi:10.3390/nu10040473 · Cited by 35
“The incidence and prevalence of Type 2 diabetes increases with age [1], and more than 30% of the elderly population in the United States are either diabetic or prediabetic [2].”
BackgroundAmri, T. A., Bahijri, S., Al-Raddadi, R. M., Ajabnoor, G., Al-Ahmadi, J., Jambi, H., Borai, A., & Tuomilehto, J. O. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s233717 · Cited by 39
Chronic Microvascular Complications in Prediabetic States—An Overview
Baranowska-Jurkun, A., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103289 · Cited by 43
“4 mg/dL, while HbA1c was a better predicative factor than FPG [42].”
BackgroundZhong, X., Yuan, M., Li, H., Hua, L., Feng, J., Shi, J. C., Zhu, X.-R., Cao, X., & Yang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040610 · Cited by 37
“Joinpoint regression, in which the relationship between the dependent and independent variables is modeled as piecewise linear phases, is used to estimate changes in trend data [12].”
MethodPrediabetes: To treat or not to treat?
Moutzouri, E., Tsimihodimos, V., Rizos, E. C., & Elisaf, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.007 · Cited by 36
Geng, P., Ding, Y., Qiu, L., & Lu, Y. (2015) · Diabetes Care · doi:10.2337/dc14-1873 · Cited by 30
Nakagami, T., Takahashi, K., Suto, C., Oya, J., Tanaka, Y., Kurita, M., Isago, C., Hasegawa, Y., Ito, A., & Uchigata, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.12.013 · Cited by 35
Butler, A. E., English, E., Kilpatrick, E. S., Östlundh, L., Chemaitelly, H. S., Abu-Raddad, L. J., Alberti, K. G. M. M., Atkin, S. L., & John, W. G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01606-5 · Cited by 36
Kharroubi, A., Darwish, H. M., Al-Halaweh, A. A., & Khammash, U. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088123 · Cited by 34
Wang, R., Miao, Z., Liu, T., Liu, M., Grdinovac, K., Song, X., Liang, Y., Delen, D., & Paiva, W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071473 · Cited by 32
Tarigan, T. J. E., Yunir, E., Subekti, I., Pramono, L. A., & Martina, D. (2015) · Medical Journal of Indonesia · doi:10.13181/mji.v24i3.1249 · Cited by 42
Zhang, B., Zhang, B., Zhou, Z., Guo, Y., & Wang, D. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00737-2 · Cited by 30
“Cheng [20] 2009 USA 153 913 ≥40 Two 45° nonmydriatic color digital images 5.”
BackgroundThe Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis
Martínez‐Vizcaíno, V., Cavero‐Redondo, I., Álvarez‐Bueno, C., & Rodríguez‐Artalejo, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154411 · Cited by 28
“Regarding the low sensitivity of FPG, the Diabetes Prevention Program [30] and NHANES [25] reported that 8% of individuals with a FPG below diabetic thresholds had retinopathy.”
BackgroundMethodZhang, R., Li, Y., Zhang, S., Cai, X., Zhou, X., & Ji, L. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4034129 · Cited by 35
“Similarly, other studies [14, 17] have also reported a high prevalence of retinopathy among people with lower FPG, and the Diabetes Prevention Program found that 8% of people with FPG below diabetic levels had retinopathy [25].”
ResultRisk factors for progression of diabetic retinopathy in Alberta First Nations communities
Rudnisky, C. J., Wong, B. K., Virani, H., & TENNANT, M. T. S. (2012) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2012.04.006 · Cited by 29
Controversies on how diabetes is diagnosed
Malkani, S., & DeSilva, T. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835168c0 · Cited by 35
Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors
Tomkin, G. H. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.636 · Cited by 24
Ilievski, V., Cho, Y., Katwala, P., Rodriguez, H., Tulowiecka, M., Kurian, D., Leoni, L., Christman, J. W., Unterman, T. G., & Watanabe, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136502 · Cited by 26
Banjar, A. A., Alyafi, R. A., AlGhamdi, A. S. T., Assaggaf, M., Almarghlani, A. A., Hassan, S., & Mealey, B. L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279755 · Cited by 32
Park, Y., Ko, S., Lee, J.-M., Kim, D. J., Kim, D. J., Han, K., Bower, J. K., & Ahn, Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.003 · Cited by 27
HbA1c and blood glucose for the diagnosis of diabetes
Misra, A., & Garg, S. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60789-7 · Cited by 23
Implications of using HBA1C as a diagnostic marker for diabetes
Hussain, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0244-9 · Cited by 24
Xu, N., Wu, H., Li, D., & Wang, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.010 · Cited by 25
Aidenloo, N. S., Mehdizadeh, A., Valizadeh, N., Abbaszadeh, M. E., Qarequran, S., & Khalkhali, H. R. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.31254 · Cited by 21
“The differences in these recommendations could partly arise due to the differences in the various studies, such as the subject population, ethnicity, or age range of the included subjects (2, 14-16).”
BackgroundVancampfort, D., Holt, R. I. G., Stubbs, B., Binder, M. D., Samaras, K., & Mitchell, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803376-0.00012-5 · Cited by 21
Evaluation of multiple risk factors involved in the development of Diabetic Retinopathy
Anwar, S. B., Asif, N., Naqvi, S. A. H., & Malik, S. Q. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.1.279 · Cited by 19
Multilocus genetic risk score for diabetic retinopathy in the Han Chinese population of Taiwan
Liao, W., Lin, J.-M., Chen, W., Hsieh, M.-C., Wu, C.-M., Chang, Y.-W., Huang, Y.-C., & Tsai, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-32916-y · Cited by 18
Matsushita, Y., Takeda, N., Nakamura, Y., Yoshida‐Hata, N., Yamamoto, S., Noda, M., Yokoyama, T., Mizoue, T., & Nakagawa, T. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3214676 · Cited by 29
Sarfati, D., McLeod, M., Stanley, J., Signal, V., Stairmand, J., Krebs, J. D., Dowell, A. C., Leung, W. C. Y., Davies, C., & Grainger, R. (2018) · Trials · doi:10.1186/s13063-018-2528-4 · Cited by 29
Risk factors for progression of diabetic retinopathy in Alberta First Nations communities
Rudnisky, C. J., Wong, B. K., Virani, H., & TENNANT, M. T. S. (2017) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2017.09.023 · Cited by 23
Cohen‐Manheim, I., Sinnreich, R., Doniger, G. M., Simon, E. S., Pinchas‐Mizrachi, R., & Kark, J. D. (2017) · European Journal of Public Health · doi:10.1093/eurpub/ckx194 · Cited by 17
Prevalence of Diabetic Retinopathy among Type - 2 Diabetes Patients in Pakistan - Vision Registry
Sohail, M. R. (2014) · Pakistan Journal of Ophthalmology · doi:10.36351/pjo.v30i4.201 · Cited by 26
Implications of Risk Stratification for Diabetes Prevention
Gregg, E. W., Geiss, L. S., Zhang, P., Zhuo, X., Williamson, D. F., & Albright, A. L. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.012 · Cited by 16
Self-citationPrediabetes: The Variation between HbA1c and Fasting Plasma Glucose
White, K. A. M., Daneshvari, S., Lilyquist, J., Luo, L., Steffen, L. E., Bivin, A., Gurule, N. J., Torres, S. M., Lindeman, R. D., Sankarappan, S., et al. (2015) · International Journal of Diabetology & Vascular Disease Research · doi:10.19070/2328-353x-si02001 · Cited by 18
“5 % have met the requisite sensitivity and specificity to identify patients at risk for developing diabetic retinopathy [13].”
BackgroundMethodDiabetic retinopathy among Brazilian Xavante Indians
Lima, C. G. M. G., Franco, L. J., Fabbro, A. L. D., Martínez, E. Z., Vieira‐Filho, J. P. B., Ventura, A. A. C. M., Prevelato, L., & Cruz, A. A. V. E. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0348-z · Cited by 13
Washirasaksiri, C., Srivanichakorn, W., Borrisut, N., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Ariyakunaphan, P., Auesomwang, C., Sayabovorn, N., Chaisathaphol, T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950225 · Cited by 17
“(Cheng et al., 2009) Furthermore, a similar relationship between IFG and cardiovascular disease was found as impaired fasting glucose carried a lower risk of cardiovascular disease than impaired glucose tolerance.”
BackgroundChan, W. C., Jackson, G., Wright, C., Orr‐Walker, B., Drury, P., Boswell, D., Lee, M. A. W., Papa, D., & Jackson, R. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003975 · Cited by 14
Dankner, R. S., Bergman, M., Danoff, A., Qureshi, S., Whitford, I., Kaviani, N., Dynkevich, Y., & Roth, J. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2373 · Cited by 15
Vitamin D supplementation modulates glycated hemoglobin (HBA1c) in diabetes mellitus
Akhter, A., Alouffi, S., Shahab, U., Akasha, R., Fazal-Ur-Rehman, M., Ghoniem, M. E., Ahmad, N., Kaur, K., Pandey, R. P., Alshammari, A. M., et al. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109911 · Cited by 14
Hemoglobin A1c for the diagnosis of diabetes: To replace or to guide oral glucose tolerance tests?
Li, H., Ma, W.-Y., Wei, J., Lin, M., Shih, S., Hung, C. S., Hua, C., & Chuang, L. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00181.x · Cited by 11
Chen, M., Xie, C., Gao, H., Zheng, H., Chen, Q., & Fang, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010252 · Cited by 16
Mostafa, S. A., Khunti, K., Kilpatrick, E., Webb, D. R., Srinivasan, B. T., Gray, L. J., & Davies, M. J. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112451473 · Cited by 12
Demissie, G. D., Birungi, J., Shrestha, A., Haregu, T., Sathish, T., & Oldenburg, B. F. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104130 · Cited by 17
Akçay, M., Aslan, A. N., Kasapkara, H. A., Ayhan, H., Durmaz, T., Keleş, T., & Bozkurt, E. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000136 · Cited by 11
“For this reason, preDM is considered a substantial risk factor for diabetes and is associated with microvascular complications and cardiovascular disease in a way similar to diabetes mellitus (DM) (4,5).”
BackgroundEspinosa, O., Pineda, O., Maydón, H., Sepúlveda, E. M., Guilbert, L., Amado, M., & Zerrweck, C. (2017) · Surgical Endoscopy · doi:10.1007/s00464-017-5815-3 · Cited by 11
Perreault, L., Færch, K., & Gregg, E. W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0899-7 · Cited by 12
Self-citationMicrovascular complications in prediabetes: a systematic review & meta-analysis
Thiab, S., Akhal, T., Akeblersane, M., Sheth, H., Atkin, S. L., & Butler, A. E. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112261 · Cited by 10
A Screening Strategy to Mitigate Vision Impairment by Engaging Adults Who Underuse Eye Care Services
Sherman, E., Niziol, L. M., Hicks, P. M., Johnson-Griggs, M. A., Elam, A. R., Woodward, M. A., Bicket, A. K., Wood, S. D., John, D. A., Johnson, L., et al. (2024) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2024.3132 · Cited by 8
The Optimal Cutoff Value of Glycated Hemoglobin for Detection of Diabetic Retinopathy
Kim, J. M., & Kim, D. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.16 · Cited by 8
“5%, using Joint point regression analysis [29].”
BackgroundMethodResultInfluentialMatsushita, Y., Yokoyama, T., Takeda, N., Katai, N., Yoshida‐Hata, N., Nakamura, Y., Yamamoto, S., Noda, M., Mizoue, T., & Nakagawa, T. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.196 · Cited by 8
Blodi, B. A., Domalpally, A., Tjaden, A. H., Barrett, N., Chew, E. Y., Knowler, W. C., Lee, C. G., Pi-Sunyer, X., Wallia, A., White, N. H., et al. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.1.13 · Cited by 9
Clinical and Biochemical Associations with Diabetic Retinopathy in Male Patients in the Gaza Strip
AbuMustafa, A. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00302 · Cited by 8
Wen, X., Ng, T. K., Zhang, G., Chen, H., Wu, Z., Liu, Q., & Zhang, M. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00297-0 · Cited by 9
“A study from the United States reported that the AUC of HbA1c is a stronger discriminator of retinopathy (0.71) than fasting plasma glucose (0.65) [33].”
InfluentialThe change points of HbA1C for detection of retinopathy in Chinese type 2 diabetic patients
Hou, J., Bi, Y., Xu, M., Huang, Y., Li, X.-Y., Wang, W., Chen, Y., & Ning, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.029 · Cited by 7
Mathematical analysis of a model for glucose regulation
Fessel, K., Gaither, J., Bower, J. K., Gaillard, T. R., Osei, K., & Rempała, G. A. (2015) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2016.13.83 · Cited by 8
Significance of prediabetes as a nosological entity
Stepanek, L., Horakova, D., Nakladalova, M., Cibickova, L., Karasek, D., & Zadrazil, J. (2018) · Biomedical Papers · doi:10.5507/bp.2018.057 · Cited by 7
Cardel, M. I., Newsome, F. A., Pearl, R. L., Ross, K. M., Dillard, J. R., Hayes, J. F., Wilfley, D. E., Keel, P. K., Dhurandhar, E. J., & Balantekin, K. N. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.09.017 · Cited by 7
Metadata
- Authors
- Cheng, Y. J., Gregg, E. W., Geiss, L. S., Imperatore, G., Williams, D. E., Zhang, X., Albright, A. L., Cowie, C. C., Klein, R., & Saaddine, J. B.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Cheng, Yiling J.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2027-2032
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768189
- OpenAlex
- W2163807150
- Cited by
- 157
- References
- 29
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 20 · 2014: 19 · 2013: 10 · 2012: 15
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, HbA1c, fasting blood glucose, glycemic control, retinopathy prevalence, retinopathy screening, diagnostic discrimination, color fundus photography, undiagnosed diabetes, NHANES
- MeSH terms
- Blood Glucose, Diabetic Angiopathies, Diabetic Retinopathy, Ethnicity, Fasting, Female, Glycated Hemoglobin, Humans, Hypertension, Male, Middle Aged, Nutrition Surveys, Sensitivity and Specificity, United States, Prevalence, Patient Selection, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

